Please try another search
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.
Name | Age | Since | Title |
---|---|---|---|
Shun Bing Yu | 60 | 2022 | Chairman of the Supervisory Committee |
Guo Ping Jiang | 62 | 2018 | Chairman |
Xiao Hua Chen | 59 | 2017 | Senior VP & Vice Chairman |
Yan Li | 47 | 2019 | President & Director |
Jiaqiu Du | 49 | 2019 | Director and Senior Vice President |
Rong Fu Fei | 37 | 2018 | Director |
Baichao Zheng | 44 | 2018 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review